This study uses a random effect panel model to examine the impact of CEO traits and compensation on earnings performance and financial leverage for the 729 listed US companies in ExecuComp over the period of 2001-2010. The results indicate that CEO cash compensation has a negative relationship with earnings performance, but that it has a positive impact on financial leverage. Moreover, for CEOs, longer tenure results in reduced earnings risk-taking for debt financing, but older CEOs generate higher earnings and increase debt capacity. In addition, it is also found that there is a negative relationship between CEO compensation and earnings for firms with poor performance. Cash compensation increases the use of debt for high leverage companies, but equity-based compensation decreases the use of debt for low leverage companies. A longer tenure and greater age also have a negative relationship with both earnings and debt financing for poor performance or low leverage companies. However, older CEOs generate more earnings and financing capacity for firms with good performance or high leverage.
This study investigates how a firm's disclosure quality affects its dividend policy. Using a sample of Canadian firms with disclosure data from The Globe and Mail, we empirically test the outcome hypothesis and the substitution hypothesis. The outcome hypothesis posits that dividends are an outcome of an effective governance regime and complements other governance mechanisms while the substitution hypothesis argues that dividend payout is a substitute for other forms of governance. Since disclosure quality can reflect the severeness of agency problems between outsiders and insiders, the outcome hypothesis predicts that higher disclosure quality would lead to higher dividend payouts while the substitution hypothesis predicts that lower disclosure quality is associated with higher payouts. This study contributes to the ongoing debate on the relationship between disclosure quality and dividend policy. Our results provide support for the outcome hypothesis; specifically, better disclosure quality is associated with both a stronger propensity to pay dividends and among dividend payers, with larger dividends.
This study explores the effect of corporate governance on financial innovation and the effect of financial innovation on performance in Taiwan’s banking industry from 2011 to 2019. The results find that the banks have higher shareholding of institutional investors, ratio of independent directors, attendance rate of directors, average education level of directors and more directors with a financial or accounting background, the greater innovative financial services offered by banks. After 2015, the impact of corporate governance on banks’ innovative financial services has increased. Moreover, the greater financial innovation services, the higher the bank profitability and value, especially after 2015. Finally, offering more innovative financial services can enhance the value of financial-holding subsidiary banks; by contrast, doing the same might negatively affect the profitability of nonfinancial-holding banks.
A credit evaluation model for SMEs in Taiwan based on the characteristics of financial as well as non-financial data is proposed in this paper. While most financial distress prediction models use financial ratios as predictive variables, this study also integrates non-financial data as predictive variables. Kuo and Li (1999) proposed that certain firm-specific financial ratios have informational content. Moreover, the introduction of non-financial variables does enhance the model's discrimination power. The proposed credit evaluation model makes it easier to classify successful or failed SMEs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.